Hikma Pharmaceuticals PLC

HKMPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$188,000$205,000$270,000$426,000
Short-Term Investments$25,000$24,000$22,000$24,000
Receivables$905,000$789,000$777,000$781,000
Inventory$986,000$891,000$776,000$695,000
Other Curr. Assets$159,000$191,000$154,000$168,000
Total Curr. Assets$2,263,000$2,100,000$1,999,000$2,094,000
Property Plant & Equip (Net)$1,326,000$1,141,000$1,081,000$1,146,000
Goodwill$382,000$388,000$389,000$285,000
Intangibles$774,000$712,000$735,000$607,000
Long-Term Investments$61,936$74,894$52,000$46,000
Tax Assets$293,099$0$192,000$183,000
Other NC Assets$32,966$264,106-$192,000-$183,000
Total NC Assets$2,870,000$2,580,000$2,257,000$2,084,000
Other Assets$0$0$215,000$194,000
Total Assets$5,133,000$4,680,000$4,471,000$4,372,000
Liabilities
Payables$358,000$309,000$291,000$262,000
Short-Term Debt$653,000$161,000$148,000$121,000
Tax Payable$78,000$74,000$73,000$57,000
Deferred Revenue$0$0$194,043$212,583
Other Curr. Liab.$889,000$795,000$370,957$363,417
Total Curr. Liab.$1,978,000$1,339,000$1,077,000$1,016,000
LT Debt$653,000$1,030,000$1,135,000$725,000
Deferred Rev, NC$29,969$7,000$1,055,000$627,000
Deferred Tax Liab, NC$18,000$25,000$19,000$24,000
Other NC Liab.$133,031$77,000-$61,000$140,000
Total NC Liab.$834,000$1,132,000$1,246,000$889,000
Other Liabilities$0$0$172,000$238,000
Cap. Leases$57,000$66,000$70,000$83,000
Total Liabilities$2,812,000$2,471,000$2,323,000$1,905,000
Equity
Pref Stock$0$0$0$0
Common Stock$40,000$40,000$40,000$42,000
Retained Earnings$2,362,000$2,158,000$2,092,000$2,189,000
AOCI$0-$281,602-$279,000-$60,000
Other Equity-$92,000$282,000$282,000$282,000
Total Equity$2,310,000$2,198,000$2,135,000$2,453,000
Supplemental Information
Minority Interest$11,000$11,000$13,000$14,000
Total Liab. & Tot. Equity$5,133,000$4,680,000$4,471,000$4,372,000
Net Debt$1,118,000$986,000$1,013,000$420,000
Hikma Pharmaceuticals PLC (HKMPF) Financial Statements & Key Stats | AlphaPilot